Primary Surgical Therapy Results in Higher 5-Year Survival for Patients With Advanced-Stage Disease


Get Permission

Bucking national trends toward preserving the larynx in patients with advanced laryngeal cancer, treatment of patients for stage IV disease at Louisiana State University (LSU) Health-Shreveport were more likely to involve primary surgical therapy, including total laryngectomy, and more likely to achieve 5-year survival than the national average. “This contributes to a growing body of literature that suggests that initial surgical therapy for advanced-stage disease may result in increased survival compared with organ-preservation protocols,” Blake Joseph LeBlanc, MD, and colleagues from LSU-Health Shreveport stated in JAMA Otolaryngology–Head & Neck Surgery.

The authors compared survival outcomes for initial surgical treatment of advanced-stage primary tumors in the Louisiana health system with outcomes in the National Cancer Database (NCDB), a joint program of the Commission on Cancer of the American College of Surgeons and the American Cancer Society. At LSU-Health, an academic tertiary referral hospital, 117 of 165 patients (70.9%) with laryngeal cancer in the tumor registry from 1998 to 2007 presented with advanced-stage (III/IV) disease, compared with 46.7% nationwide (P < .01). Among the LSU patients with advanced disease, 64 patients (54.70%) underwent primary surgical therapy, including total laryngectomy or pharyngolaryngectomy. “Data from the NCDB indicate that the rate of laryngectomy declined from 40% to 60% in the 1980s to 32% in 2007,” the investigators noted.

“For stage IV disease, our 5-year survival rate was 55.54% (95% CI, 43.4%–66.1%) compared with 31.6% (95% CI, 30.4%–32.9%) nationally (P < .05). Our proportion of uninsured patients was 23.7% vs 5.1% of patients nationally (P < .001), and our patients traveled farther distances for care, with 60.5% traveling 50 miles or more, compared with 15.9% nationally (P < .001),” Dr. LeBlanc and coauthors reported. “We believe that upfront laryngectomy may explain our higher survival rates for advanced-stage laryngeal cancer,” the authors stated.

“While it seems logical that triple-modality therapy would confer improved survival at the expense of increased morbidity, the question arises as to whether we should be advising upfront surgical therapy more frequently for the advanced T-stage tumors,” the researchers wrote. “Current National Comprehensive Cancer Network guidelines display the options of concurrent systemic therapy vs laryngectomy vs induction chemotherapy for advanced T-stage glottic and supraglottic carcinomas. At our institution, [patients with] T4 tumors with cartilage and extralaryngeal involvement are uniformly offered total laryngectomy in favor of organ preservation, which resulted in a higher percentage of primary surgical patients at LSU-Health when compared with the NCDB.”

LSU-Health Shreveport “is a public hospital with a large proportion of uninsured and Medicaid [patients] and those with low socioeconomic status,” the authors noted. “Our data suggest that despite disparities in insurance and socioeconomic status, improvements in survival can be achieved with primary surgical
treatment.” ■

LeBlanc BJ, et al: JAMA Otolaryngol Head Neck Surg. November 27, 2014 (early release online).


Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.